Star Equity Holdings, Inc. Issues Business Update
Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP) provided an update on its 2021 achievements and 2022 objectives. The Healthcare division achieved a record of 39 diagnostic cameras sold, prompting a look into potential acquisitions, particularly in healthcare staffing. The Construction division also saw improved performance, producing 350 modular units and a $65 million sales pipeline, with a notable $8-9 million project for student housing. The company aims to enhance production capacity and examine acquisition opportunities while expecting improved profitability in 2022.
- Healthcare division sold 39 diagnostic cameras in 2021, up from 16 in 2020.
- Construction division produced 350 modular units in 2021, a significant increase from previous years.
- Sales pipeline in Construction valued at approximately $65 million, including a potential $8-9 million project.
- Expectations of improved profitability in Construction division for 2022.
- No financial metrics reported in the PR regarding overall revenue or profitability.
- Uncertainty in potential acquisitions and their impact on financials.
OLD GREENWICH, Conn., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP) (“Star Equity” or the “Company”), a diversified holding company, provided today an update on key achievements in 2021 as well as its sales pipeline and acquisitions initiatives for 2022.
Healthcare:
The Healthcare division’s Diagnostic Imaging business sold a record 39 cameras in 2021 compared to 16 in 2020 and 31 in 2019. With the Healthcare division as a whole having rebounded to more normal levels, the Company has begun to consider potential bolt on acquisition targets for the division, particularly in the area of healthcare staffing. Although there can be no certainty of a transaction occurring, the Company believes healthcare staffing is a natural addition to its existing Healthcare businesses and is eager to explore synergies with Digirad Health’s current distribution channels, client base, and support for its own internal healthcare staffing needs. Furthermore, Rick Coleman, Star Equity’s recently appointed Chief Operating Officer, has substantial experience and success in the staffing industry, most recently as CEO of Command Center, Inc., which merged with HireQuest, Inc. (Nasdaq: HQI) in 2019.
Construction:
The Company’s Construction division also saw improved results in both of its businesses: KBS Builders, Inc. (“KBS”) based in New England and EdgeBuilder/Glenbrook (“EBGL”) based in Minnesota. KBS produced approximately 350 modular units in 2021 compared to 280 units in 2020 and 230 units in 2019. The Company believes production capacity at KBS’s South Paris, ME plant is approximately 500 modules per year and is working diligently to attain this production level. The Company has a goal of reopening its idle Oxford, ME plant, which would increase KBS’s total production capacity to 750-1,000 modules per year. In addition, KBS’s sales pipeline, which represents potential projects that could be won over the next 12 months, is approximately
“We are highly encouraged with the revenue growth at our Construction division in 2021,” said Jeff Eberwein, Star Equity’s Executive Chairman. “We are confident in the growth outlook for our Construction division in 2022 and expect profitability to improve significantly. At the same time, we are evaluating bolt on acquisition opportunities for both Healthcare and Construction in addition to exploring entry into new business sectors.”
The Company will provide additional financial and operating results in its complete fourth quarter and full-year 2021 earnings press release and conference call that will be announced at a later date.
About Star Equity Holdings, Inc.
Star Equity Holdings, Inc. is a diversified holding company with three divisions: Healthcare, Construction, and Investments.
Healthcare
Our Healthcare division designs, manufactures, and distributes diagnostic medical imaging products and provides mobile imaging services. Our Healthcare division operates in two businesses: (i) diagnostic services and (i) diagnostic imaging. The diagnostic services business offers imaging services to healthcare providers as an outsourced alternative to purchasing and operating their own equipment. The diagnostic imaging business develops, sells, and maintains solid-state gamma cameras.
Construction
Our Construction division manufactures modular housing units for commercial and residential real estate projects and operates in two businesses: (i) modular building manufacturing and (ii) structural wall panel and wood foundation manufacturing, including building supply distribution operations for professional builders.
Investments
Our Investments division manages and finances the Company’s real estate assets and investments.
Forward-Looking Statements
“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements in this release that are not statements of historical fact are hereby identified as “forward-looking statements” for the purpose of the safe harbor provided by Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking Statements include, without limitation, statements regarding (i) the plans and objectives of management for future operations, including plans or objectives relating to acquisitions and related integration, development of commercially viable products, novel technologies, and modern applicable services, (ii) projections of income (including income/loss), EBITDA, earnings (including earnings/loss) per share, free cash flow (FCF), capital expenditures, cost reductions, capital structure or other financial items, (iii) the future financial performance of the Company or acquisition targets and (iv) the assumptions underlying or relating to any statement described above. Moreover, forward-looking statements necessarily involve assumptions on the Company’s part. These forward-looking statements generally are identified by the words “believe”, “expect”, “anticipate”, “estimate”, “project”, “intend”, “plan”, “should”, “may”, “will”, “would”, “will be”, “will continue” or similar expressions. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events, or circumstances and may not be realized because they are based upon the Company's current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other influences, many of which the Company has no control over. Actual results and the timing of certain events and circumstances may differ materially from those described above as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of forward-looking statements or cause actual results to differ materially from expected or desired results may include, without limitation, the substantial amount of debt of the Company and the Company’s ability to repay or refinance it or incur additional debt in the future; the Company’s need for a significant amount of cash to service and repay the debt and to pay dividends on the Company’s preferred stock; the restrictions contained in the debt agreements that limit the discretion of management in operating the business; legal, regulatory, political and economic risks in markets and public health crises that reduce economic activity and cause restrictions on operations (including the recent coronavirus COVID-19 outbreak); the length of time associated with servicing customers; losses of significant contracts or failure to get potential contracts being discussed; disruptions in the relationship with third party vendors; accounts receivable turnover; insufficient cash flows and resulting lack of liquidity; the Company's inability to expand the Company's business; unfavorable changes in the extensive governmental legislation and regulations governing healthcare providers and the provision of healthcare services and the competitive impact of such changes (including unfavorable changes to reimbursement policies); high costs of regulatory compliance; the liability and compliance costs regarding environmental regulations; the underlying condition of the technology support industry; the lack of product diversification; development and introduction of new technologies and intense competition in the healthcare industry; existing or increased competition; risks to the price and volatility of the Company’s common stock and preferred stock; stock volatility and in liquidity; risks to preferred stockholders of not receiving dividends and risks to the Company’s ability to pursue growth opportunities if the Company continues to pay dividends according to the terms of the Company’s preferred stock; the Company’s ability to execute on its business strategy (including any cost reduction plans); the Company’s failure to realize expected benefits of restructuring and cost-cutting actions; the Company’s ability to preserve and monetize its net operating losses; risks associated with the Company’s possible pursuit of acquisitions; the Company’s ability to consummate successful acquisitions and execute related integration, as well as factors related to the Company’s business including economic and financial market conditions generally and economic conditions in the Company’s markets; failure to keep pace with evolving technologies and difficulties integrating technologies; system failures; losses of key management personnel and the inability to attract and retain highly qualified management and personnel in the future; and the continued demand for and market acceptance of the Company’s services. For a detailed discussion of cautionary statements and risks that may affect the Company’s future results of operations and financial results, please refer to the Company’s filings with the Securities and Exchange Commission, including, but not limited to, the risk factors in the Company’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. This release reflects management’s views as of the date presented.
All forward-looking statements are necessarily only estimates of future results, and there can be no assurance that actual results will not differ materially from expectations, and, therefore, you are cautioned not to place undue reliance on such statements. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events.
| For more information contact: | |
| Star Equity Holdings, Inc. | The Equity Group |
| Jeffrey E. Eberwein | Lena Cati |
| Executive Chairman | Vice President |
| 203-489-9501 | 212-836-9611 |
| admin@starequity.com | lcati@equityny.com |
FAQ
What achievements did Star Equity Holdings report for 2021?
What is the sales pipeline for Star Equity in the Construction division?
What acquisitions is Star Equity considering?
What are the expectations for Star Equity's profitability in 2022?
